DNDi is very pleased to announce the renewed commitment of the Global Health Innovative Technology Fund (GHIT), its donor since 2013, to DNDi projects on leishmaniasis and Chagas disease.
The Malaysian Reserve [19 January, 2017]
“Doctors should be more involved in research”
Borneo Post Online [19 January, 2017]
“Health Ministry aims to lower treatment cost for hepatitis C”
The Huffington Post [17 January, 2017]
“This man went abroad and brought back a disease U.S. doctors had never seen”
The Huffington Post [20 December, 2016]
“A parasite attacked this dad’s brain and destroyed his family”
The Huffington Post [13 December, 2016]
“How disease detectives unearthed a forgotten drug to fight a lethal illness”
Toremaga [8 December, 2016]
“スーダン・ハルツーム大学のアーメド ファハル外科教授が来日 重篤な感染症「マイセトーマ(菌腫)」について講演を行う” – “Professor Ahmed Fahal, surgeon from Sudan / Khartoum University will give a lecture on the serious infectious disease: Mycetoma”
The Huffington Post [6 December, 2016]
“18 diseases the world has turned its back on”
Ärzteblatt [1 December, 2016]
“Mehr Geld für die Forschung zu armutsbedingten Erkrankungen” – “More money for research on poverty-related diseases”
The Huffington Post [1 December, 2016]
“This group helps fight devastating diseases the world ignores”
WuXi App Tec [1 December, 2016]
“Harnessing science for the most neglected diseases – A chat with Charles Mowbray, Ph.D., Head of Drug Discovery, DNDi“
KfW, on behalf of the Federal Ministry of Education and Research (BMBF), grants EUR 10 Million to DNDi
DNDi has been awarded EUR 10 million towards the development of treatments against sleeping sickness, visceral leishmaniasis, Chagas disease, and filarial diseases. The grant will be starting this year and be disbursed over five years.
The Huffington Post [29 November, 2016]
“This doctor gave up his shot at a cushy career to cure a little known-disease”
The Huffington Post [23 November, 2016]
“A killer disease might be nearing the end of its deadly run”
[21 September, 2016]
The Drugs for Neglected Diseases initiative (DNDi) welcomes the commitment made by world leaders today at the United Nations (UN) General Assembly to address one of the world’s most pressing public health issues, antimicrobial resistance (AMR).
[14 September, 2016]
The Drugs for Neglected Diseases initiative (DNDi) today welcomes the release of the report of the United Nations Secretary General’s High-Level Panel on Access to Medicines. The Panel has clearly confirmed the policy misalignment between intellectual property and trade rules, international human rights obligations, and public health objectives. It has underlined many immediate access challenges and steps that must be taken to overcome them, and highlighted that existing funding and incentive mechanisms are not adequate to stimulate innovation to address global public health needs.
GHIT awarded US$687,715 to a partnership between GeneDesign, a Japan-based biotech, and DNDi to develop a better treatment for cutaneous leishmaniasis.